Format

Send to

Choose Destination
Clin Infect Dis. 2017 Mar 15;64(suppl_1):S41-S47. doi: 10.1093/cid/ciw831.

Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.

Author information

1
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, and.
2
Emergency Medicine Service, Durham Veterans Affairs Medical Center, Durham, North Carolina.
3
Public Health Research Institute Tuberculosis Center, New Jersey Medical School-Rutgers University, Newark.
4
Department of Medicine, Case Western Reserve University School of Medicine, and.
5
Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio.
6
Division of Pediatric Infectious Diseases, Vanderbilt University, Nashville, Tennessee.
7
Department of Medicine, Division of Infectious Diseases, the University of Pennsylvania School of Medicine, Philadelphia.
8
Center for Biostatistics in AIDS Research and the Department of Biostatistics, Harvard University, Boston, Massachusetts.
9
Departments of Medicine and Pathology, Divisions of Infectious Diseases and Clinical Microbiology, University of Utah, Salt Lake City.
10
UCLA David Geffen School of Medicine and Fielding School of Public Health, Los Angeles, California.
11
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Abstract

Diagnostics are a cornerstone of the practice of infectious diseases. However, various limitations frequently lead to unmet clinical needs. In most other domains, diagnostics focus on narrowly defined questions, provide readily interpretable answers, and use true gold standards for development. In contrast, infectious diseases diagnostics must contend with scores of potential pathogens, dozens of clinical syndromes, emerging pathogens, rapid evolution of existing pathogens and their associated resistance mechanisms, and the absence of gold standards in many situations. In spite of these challenges, the importance and value of diagnostics cannot be underestimated. Therefore, the Antibacterial Resistance Leadership Group has identified diagnostics as 1 of 4 major areas of emphasis. Herein, we provide an overview of that development, highlighting several examples where innovation in study design, content, and execution is advancing the field of infectious diseases diagnostics.

KEYWORDS:

antibacterial resistance; devices.; diagnostics

PMID:
28350903
PMCID:
PMC5848376
DOI:
10.1093/cid/ciw831
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center